🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 17 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/01/2000 | 48,42 | 49,36 | 47,96 | 49,13 | +0,00% | 2,90% | 113.947 |
| 04/01/2000 | 51,70 | 51,93 | 48,19 | 49,13 | -5,41% | 7,24% | 131.499 |
| 03/01/2000 | 51,00 | 51,93 | 48,66 | 51,93 | +7,77% | 6,42% | 207.001 |
| 31/12/1999 | 47,26 | 48,42 | 46,32 | 48,19 | +3,00% | 4,46% | 145.312 |
| 30/12/1999 | 50,53 | 50,53 | 46,55 | 46,79 | -1,96% | 7,87% | 456.267 |
| 29/12/1999 | 41,41 | 51,93 | 40,47 | 47,72 | +14,61% | 27,68% | 629.658 |
| 28/12/1999 | 41,64 | 41,64 | 40,70 | 41,64 | +0,00% | 2,25% | 75.742 |
| 27/12/1999 | 42,11 | 42,34 | 40,94 | 41,64 | +0,00% | 3,33% | 77.585 |
| 23/12/1999 | 41,87 | 42,34 | 40,70 | 41,64 | +5,33% | 3,91% | 118.542 |
| 22/12/1999 | 38,13 | 40,70 | 37,90 | 39,54 | +4,32% | 7,36% | 59.845 |
| 21/12/1999 | 39,77 | 41,64 | 37,43 | 37,90 | -1,22% | 10,59% | 84.264 |
| 20/12/1999 | 37,66 | 39,30 | 37,43 | 38,37 | +3,80% | 4,97% | 87.711 |
| 17/12/1999 | 37,20 | 37,43 | 36,49 | 36,96 | +1,61% | 2,52% | 94.043 |
| 16/12/1999 | 37,20 | 37,66 | 36,03 | 36,38 | -2,51% | 4,40% | 127.813 |
| 15/12/1999 | 37,66 | 39,54 | 36,03 | 37,31 | -7,27% | 9,32% | 175.716 |
| 14/12/1999 | 44,68 | 44,68 | 38,13 | 40,24 | -8,02% | 14,66% | 437.753 |
| 13/12/1999 | 43,75 | 43,75 | 43,75 | 43,75 | +0,00% | 0,00% | 294 |
| 10/12/1999 | 43,04 | 44,21 | 42,34 | 43,75 | +2,75% | 4,35% | 261.476 |
| 09/12/1999 | 42,58 | 42,58 | 41,41 | 42,58 | +1,11% | 2,75% | 146.755 |
| 08/12/1999 | 42,58 | 43,04 | 41,64 | 42,11 | +1,69% | 3,30% | 211.436 |
| 07/12/1999 | 40,94 | 41,64 | 40,24 | 41,41 | +2,91% | 3,43% | 86.322 |
| 06/12/1999 | 41,41 | 41,64 | 40,24 | 40,24 | -2,27% | 3,39% | 65.055 |
| 03/12/1999 | 40,24 | 42,11 | 40,00 | 41,17 | +2,92% | 5,23% | 97.543 |
| 02/12/1999 | 40,00 | 40,24 | 38,37 | 40,00 | +0,00% | 4,68% | 83.944 |
| 01/12/1999 | 43,51 | 43,75 | 38,83 | 40,00 | -7,07% | 11,29% | 145.713 |
| 30/11/1999 | 41,64 | 44,45 | 41,17 | 43,04 | +4,55% | 7,87% | 350.175 |
| 29/11/1999 | 39,54 | 42,11 | 39,30 | 41,17 | +7,98% | 7,10% | 194.123 |
| 26/11/1999 | 36,73 | 38,37 | 36,61 | 38,13 | +4,49% | 4,78% | 83.997 |
| 24/11/1999 | 36,26 | 36,96 | 35,56 | 36,49 | +2,63% | 3,87% | 41.438 |
| 23/11/1999 | 36,26 | 36,26 | 34,86 | 35,56 | +1,33% | 3,87% | 59.712 |